Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10244702 | 0.94 | KEAP1 (0.49) | DNM1KDM4EKEAP1NFE2L2PAOX | |
| SCHEMBL36169 | 0.89 | DNM1 (0.55) | DNM1KDM4EPAOXHPGDPOLB | |
| Hydrochloric Acid SCHEMBL10730965 | 0.86 | DNM1 (0.53) | DNM1KDM4EPAOXHPGDPOLB | |
| SCHEMBL836639 | 0.86 | PRMT3 (0.46) | DNM1KEAP1NFE2L2POLBALDH1A1 | |
| SCHEMBL24102742 | 0.84 | DNM1 (0.52) | DNM1KDM4EPAOXHPGDPOLB | |
| SCHEMBL11149127 | 0.84 | EPHX1 (0.58) | DNM1KDM4EPAOXHPGDEPHX1 | |
| SCHEMBL19672893 | 0.83 | KDM4E (0.47) | DNM1KDM4EPAOXHPGDPOLB | |
| SCHEMBL12707843 | 0.83 | DNM1 (0.50) | DNM1KDM4EPAOXHPGDPOLB | |
| SCHEMBL11382117 | 0.81 | KEAP1 (0.55) | KDM4EKEAP1NFE2L2MEN1KMT2A | |
| SCHEMBL13466509 | 0.81 | KEAP1 (0.61) | KDM4EKEAP1NFE2L2PAOXPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120064482-A | Method for simultaneously detecting mussel mucin and recombinant type III collagen | 哈尔滨斯达生物科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-20210078949-A1 | METHODS FOR PREPARATION OF JASMONATE COMPOUNDS | VIDAC PHARMA LTD. (IL) | 2021-03-18 | — | — | US | disclosed |
| US-8354418-B2 | Thiazolyl-dihydro-quinazolines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-01-15 | — | — | US | disclosed |
| US-8097708-B2 | 10a-Azalide compound | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-01-17 | — | — | US | disclosed |
| US-8097708-B2 | 10a-Azalide compound | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-01-17 | — | — | US | disclosed |
| EP-2114945-B1 | PTERIDINONE DERIVATIVES AS PI3-KINASES INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2010-10-20 | — | — | EP | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090131424-A1 | THIAZOLYL-DIHYDRO-CHINAZOLINE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-21 | — | — | US | disclosed |
| US-20070238746-A1 | THIAZOLYL-DIHYDRO-CHINAZOLINE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238746-A1 | THIAZOLYL-DIHYDRO-CHINAZOLINE | CYP3A7, UGT2B7, UGT1A7 | DNM1 3228/4885KDM4E 4490/4885KEAP1 899/4885 |
| US-20090131424-A1 | THIAZOLYL-DIHYDRO-CHINAZOLINE | CYP3A7, UGT2B7, UGT1A7 | DNM1 3228/4885KDM4E 4490/4885KEAP1 899/4885 |
| US-20210078949-A1 | METHODS FOR PREPARATION OF JASMONATE COMPOUNDS | SQLE, FDFT1, FDPS | DNM1 951/4885KDM4E 2493/4885KEAP1 151/4885 |
| US-20090281292-A1 | 10a-Azalide Compound | IL17A, AZI2, HDAC9 | DNM1 3156/4885KDM4E 128/4885KEAP1 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.